Filing Details
- Accession Number:
- 0001415889-24-016364
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-11 16:30:07
- Reporting Period:
- 2024-06-07
- Accepted Time:
- 2024-06-11 16:30:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-06-07 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-06-07 | 770 | $275.33 | 2,960 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-07 | 802 | $276.36 | 2,158 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-07 | 1,067 | $277.38 | 1,091 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-07 | 600 | $278.61 | 491 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-07 | 361 | $279.45 | 130 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-06-10 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-06-10 | 446 | $270.88 | 3,284 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-10 | 608 | $272.74 | 2,676 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-10 | 491 | $273.46 | 2,185 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-10 | 1,305 | $274.72 | 880 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-06-10 | 750 | $275.71 | 130 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2024-06-07 | 3,600 | $0.00 | 3,600 | $129.49 |
Common Stock | Stock Options | Disposition | 2024-06-10 | 3,600 | $0.00 | 3,600 | $129.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
191,069 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
187,469 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 166 | Indirect | By Spouse |
Common Stock | 245,909 | Indirect | By Trust |
Common Stock | 2,706 | Indirect | By Trust |
Common Stock | 28,170 | Indirect | By Trust |
Common Stock | 324,518 | Indirect | By Trust |
Common Stock | 45,596 | Indirect | By Trust |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $274.82 to $275.745. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $275.83 to $276.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $277.06 to $277.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $278.065 to $279.055. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $279.075 to $280.035. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $270.425 to $271.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $272.08 to $273.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $273.14 to $273.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $274.155 to $275.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $275.22 to $275.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person is sole trustee and members of the Reporting Person's immediate family are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.